PEOPLE - Hemagen Diagnostics (US) makes appointment:
This article was originally published in Clinica
US company Hemagen Diagnostics has appointed Paul Fruitt to its board of directors. Mr Fruitt, a former vice-president of corporate planning at Gillette, replaces Dr John Sandson who died after a brief illness in November.
You may also be interested in...
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.